Add to ORKGUtilizing 34 348 severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) nucleic acid amplification test (NAAT) results from 2 health systems, we estimated the clinical sensitivity of a single SARS-CoV-2 NAAT. We found that SARS-CoV-2 NAAT has 82%-97% sensitivity for diagnosing coronavirus disease 2019 among symptomatic patients
The gold standard in the definitive diagnosis of severe acute respiratory syndrome coronavirus-2 (SA...
COVID-19 pandemic ignited the development of countless molecular methods for the diagnosis of SARS-C...
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus dis...
Utilizing 34 348 severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) nucleic acid amplifica...
Background: Management and control of coronavirus disease 2019 (COVID-19) relies on reliable diagnos...
There are numerous tests available for acute diagnosis of SARS-CoV-2, the virus that causes the dise...
BackgroundA number of nucleic acid amplification tests (NAATs) for SARS-CoV-2 with different reagent...
Rapid COVID-19 diagnosis in the hospital is essential, although this is complicated by 30%–50% of no...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the etiologic agent a...
Rapid COVID-19 diagnosis in the hospital is essential, although this is complicated by 30%-50% of no...
Rapid COVID-19 diagnosis in the hospital is essential, although this is complicated by 30%-50% of no...
A new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently emerge...
The early detection and differential diagnosis of respiratory infections increase the chances for su...
ObjectivesDiagnostic tests for SARS-CoV-2 are important for epidemiology, clinical management, and i...
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SA...
The gold standard in the definitive diagnosis of severe acute respiratory syndrome coronavirus-2 (SA...
COVID-19 pandemic ignited the development of countless molecular methods for the diagnosis of SARS-C...
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus dis...
Utilizing 34 348 severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) nucleic acid amplifica...
Background: Management and control of coronavirus disease 2019 (COVID-19) relies on reliable diagnos...
There are numerous tests available for acute diagnosis of SARS-CoV-2, the virus that causes the dise...
BackgroundA number of nucleic acid amplification tests (NAATs) for SARS-CoV-2 with different reagent...
Rapid COVID-19 diagnosis in the hospital is essential, although this is complicated by 30%–50% of no...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the etiologic agent a...
Rapid COVID-19 diagnosis in the hospital is essential, although this is complicated by 30%-50% of no...
Rapid COVID-19 diagnosis in the hospital is essential, although this is complicated by 30%-50% of no...
A new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently emerge...
The early detection and differential diagnosis of respiratory infections increase the chances for su...
ObjectivesDiagnostic tests for SARS-CoV-2 are important for epidemiology, clinical management, and i...
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SA...
The gold standard in the definitive diagnosis of severe acute respiratory syndrome coronavirus-2 (SA...
COVID-19 pandemic ignited the development of countless molecular methods for the diagnosis of SARS-C...
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus dis...